Fundacio Hospital Universitari Vall D’Hebron Institut De Recerca

• Phase I, single and multiple ascending dose, randomized, double-blind, placebo-controlled, parallel-group clinical trial to evaluate the saf… Not authorised
  2024-518758-18-00 Phase I 1 country
• Insulin resistance in type 2 diabetes: evaluating the pathogenic mechanisms of insulin resistance in the myocardium and the effects of the t… Not authorised
  2025-523374-17-01 Phase IV 1 country DAPAGLIFLOZIN PROPANEDIOL; SEMAGLUTIDE
• Tolerability and acceptance of two oral hydrocortisone medications for Pediatrics. Pending
  2024-519149-31-00 Phase IV 1 country
• MULTICENTER, RANDOMIZED STUDY TO EVALUATE THE EFFICACY OF INDIVIDUALIZATION OF IMMUNOLOGICAL RISK BASED ON SELECTIVE BIOMARKERS (HLA EPLE… Pending
  2025-520884-42-00 Phase IV 1 country BASILIXIMAB; METHYLPREDNISOLONE; MYCOPHENOLATE MOFETIL; PREDNISONE; RABBIT ANTI-…
• Phase IV, single-center, randomized, crossover clinical trial to validate the use of gadopiclenol versus gadobutrol in the evaluation of mag… Pending
  2025-523278-18-00 Phase IV 1 country GADOBUTROL; GADOPICLENOL
• Phase IV, randomized, open label, parallel groups clinical trial for evaluating the early Stop of antibiotic Treatment in high-risk febrile … Pending
  2025-524264-38-00 Phase IV 1 country
• Optimizing Aspirin Use for Preeclampsia Prevention Pending
  2025-524646-94-00 Phase III/IV 1 country
• Phase IV study to evaluate the safety and efficacy of maribavir in reducing Epstein–Barr virus in young adult kidney transplant recipients. Pending
  2025-524786-25-00 Phase IV 1 country MARIBAVIR
• Randomized Cross-Over Experimental Trial of Treatment with Sumatriptan vs. Rimegepant During Nitroglycerin (NTG)-Induced Headache in Patient… Recruiting
  2024-519770-38-00 Phase IV 1 country
• Phase I, single and multiple ascending dose, randomized, double-blind, placebo-controlled, parallel-group clinical trial to evaluate the saf… Recruiting
  2024-518758-18-02 Phase I 1 country
• A randomized controlled study to assess the efficacy of topical Sinecathechins used as adjuvant therapy to topical ablative trichloroacetic … Recruiting
  2024-519782-21-00 Phase IV 1 country
• Rifampicin at High Dose for Difficult-to-Treat Tuberculosis (RIAlta) study Recruiting
  2024-519983-42-00 Phase II 2 countries ISONIAZID, PYRAZINAMIDE, RIFAMPICIN, ETHAMBUTOL HYDROCHLORIDE; RIFAMPICIN
• Clinical Efficacy of oral Fosfomycin Trometamol and Cefixime in the Treatment of Acute Bacterial Prostatitis (CEFOSPROST): a comparative, ra… Recruiting
  2024-513465-39-00 Phase IV 1 country
• Preoperative Indocyanine Green administration increases intraoperative detection of Liver Tumors in Imaging-guided surgery. A phase IV clini… Recruiting
  2023-508316-27-00 Phase IV 1 country
• Multicenter, randomized, double-blind, comparative clinical trial to assess the efficacy of Zinc Acexamate versus a placebo in improving the… Recruiting
  2024-518242-24-00 Phase III 1 country ZINC ACEXAMATE
• IMMUNE RESET TO ALLOW ACCESS TO HLA-COMPATIBLE KIDNEY TRANSPLANTATION IN HYPERIMMUNIZED PATIENTS Ended
  2023-506478-11-01 Phase I/II 1 country
• Clinical trial with ivermectin to treat strongyloidiasis with the aim of demonstrating that both the independent and weight-dependent dose o… Ended
  2024-515968-32-00 Phase II 1 country
• RANDOMIZED, CONTROLLED, OPEN, MULTICENTRIC CLINICAL TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF A COMBINATION OF ANTI-TUBERCULOUS DRUGS BAS… Ended
  2023-509075-17-00 Phase II 1 country ISONIAZID, PYRAZINAMIDE, RIFAMPICIN, ETHAMBUTOL HYDROCHLORIDE; LINEZOLID; MOXIFL…

Showing 1–18 of 18 trials